HSA
ABBV icon

Hussman Strategic Advisors’s AbbVie ABBV Stock Holding History

Hussman Strategic Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,500
Closed -$1.57M – 223
2023
Q3 		$1.57M Sell
10,500
-5,100
-33% -$749K 0.3% 143
2023
Q2 		$2.1M Sell
15,600
-3,000
-16% -$440K 0.39% 109
2023
Q1 		$2.96M Sell
18,600
-12,400
-40% -$1.9M 0.47% 75
2022
Q4 		$5.01M Hold
31,000
– – 0.82% 20
2022
Q3 		$4.16M Hold
31,000
– – 0.72% 29
2022
Q2 		$4.75M Buy
31,000
+25,800
+496% +$3.94M 0.82% 18
2022
Q1 		$843K Hold
5,200
– – 0.16% 199
2021
Q4 		$704K Sell
5,200
-7,200
-58% -$851K 0.15% 206
2021
Q3 		$1.34M Sell
12,400
-3,100
-20% -$354K 0.3% 135
2021
Q2 		$1.75M Sell
15,500
-13,300
-46% -$1.5M 0.36% 109
2021
Q1 		$3.12M Buy
+28,800
New +$3.08M 0.64% 37
2020
Q3 		– Sell
-25,500
Closed -$2.5M – 261
2020
Q2 		$2.5M Buy
25,500
+5,000
+24% +$440K 0.64% 41
2020
Q1 		$1.56M Buy
+20,500
New +$1.75M 0.42% 87
2018
Q3 		– Sell
-25,000
Closed -$2.32M – 219
2018
Q2 		$2.32M Buy
+25,000
New +$2.44M 0.62% 68
2018
Q1 		– Sell
-25,000
Closed -$2.42M – 216
2017
Q4 		$2.42M Buy
+25,000
New +$2.36M 0.69% 72
2015
Q1 		– Sell
-100,000
Closed -$6.54M – 186
2014
Q4 		$6.54M Hold
100,000
– – 0.65% 66
2014
Q3 		$5.78M Sell
100,000
-200,000
-67% -$11.1M 0.49% 87
2014
Q2 		$16.9M Sell
300,000
-3,250
-1% -$170K 1.3% 18
2014
Q1 		$15.6M Hold
303,250
– – 1.17% 29
2013
Q4 		$16M Sell
303,250
-100,000
-25% -$4.91M 1.14% 29
2013
Q3 		$18M Hold
403,250
– – 0.99% 41
2013
Q2 		$16.7M Buy
+403,250
New +$17.6M 0.76% 61

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Hussman Strategic Advisors's ABBV Position: Q4 2023 in Review

Hussman Strategic Advisors sold out of AbbVie (ABBV) in Q4 2023, closing a stake of 10,500 shares — an estimated $1.57M sold.

Hussman Strategic Advisors first reported a position in ABBV in Q2 2013 and held it in 22 quarters. The position peaked at $18M in Q3 2013. 3,327 funds tracked by Wall St. Rank hold ABBV as of Q4 2023.

  • Hussman Strategic Advisors reported no remaining AbbVie position as of Q4 2023 after selling out during the quarter.
  • Hussman Strategic Advisors sold 10,500 AbbVie shares in Q4 2023, an estimated $1.57M.
  • Hussman Strategic Advisors first reported a position in AbbVie in Q2 2013 and held it in 22 quarters.
  • Hussman Strategic Advisors's AbbVie position peaked at $18M in Q3 2013.
  • 3,327 funds tracked by Wall St. Rank held AbbVie as of Q4 2023.

Based on Hussman Strategic Advisors's 13F filing for Q4 2023, filed 1 Feb 2024.